Preservation of post-transplant lung function with aerosol cyclosporin

European Respiratory Journal

Volumn 23, Issue 3, 2004, Pages 378-383

  Corcoran, T E ^a,e   Smaldone, G C ^b   Dauber, J H ^a   Smith, D A ^a   McCurry, K R ^c   Burckart, G J ^c   Zeevi, A ^c   Griffith, B P ^d   Iacono, A T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Aerosol cyclosporin; Aerosol deposition; Lung transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; TACROLIMUS;

AEROSOL; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; FORCED EXPIRATORY VOLUME; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LINEAR SYSTEM; LUNG FUNCTION; LUNG TRANSPLANTATION; NEBULIZATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRANSBRONCHIAL BIOPSY;

ADMINISTRATION, INHALATION; AEROSOLS; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; POSTOPERATIVE PERIOD;

EID: 1542714401     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00059204     Document Type: Article

References (9)

1. Husain AN, Siddiqui MT, Holmes, et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999; 159: 829-833.
2. Reichenspurner H, Girgis RE, Robbins RC, et al. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 1996; 62: 1467-1473.
3. Valentine VG, Robbins RC, Berry GJ, et al. Actuarial survival of heart-lung and bilateral sequential lung-transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996; 15: 371-383.
4. Keenan RJ, Iacono AT, Dauber JH, et al. Treatment of refractory acute rejection associated with aerosolized cyclosporine in lung transplant recipients. J Thorac Cardiovasc Surg 1997; 113: 335-341.
5. Iacono AT, Smaldone GC, Keenan RJ, et al. Dose-related reversal of acute lung rejection by aerosolized cyclosporine. Am J Respir Crit Care Med 1997; 155: 1690-1698.
6. Iacono AT, Keenan RJ, Duncan SR, et al. Aerosolized cyclopsorine in lung recipients with refractory chronic rejection. Am J Respir Crit Care Med 1996; 153: 1451-1455.
7. Sangwan S, Agosti JM, Bauer LA, et al. Aerosolized protein delivery in asthma: Gamma camera analysis of regional deposition and perfusion. J Aerosol Med 2001; 14: 185-195.
8. Yousem AA, Berry GJ, Cagle PT, et al. A revision of the 1990 working formulation of the classification of pulmonary allograft rejection: Lung rejection study group. J Heart Lung Transplant 1996; 15: 1-15.
9. Motulsky H. Intuitive Biostatistics. New York, Oxford University Press, 1995.